Biopreservation Market Report and Forecast 2025-2034

The global biopreservation market reached a value of D 6.40 Billion in 2024, driven by the growing demand for biobanking and regenerative medicines across the globe. The market is further expected to grow at a CAGR of about 14.40% in the forecast period of 2025-2034 to reach a value of around USD 24.57 Billion by 2034.

Biopreservation Market Overview

Biopreservation is a process used to preserve bio-products such as stem cells, DNA, tissues, and organs. It is designed to maintain the effectiveness and functions of these products under varying conditions. Microarrays and predictive models, which have been developed along with API algorithms, are the technologies that cut the process's duration, cost, and complexity. Multiplex cellular imaging platforms are predicted to effectively explain disease progression and make suitable diagnoses and treatments. Biopreservation has become very popular in hospitals and labs because of the use of more products, funds from the government and partners, and many other research and development tasks, as well as the development of new products.

Biopreservation Market Growth Drivers

Rising Demand for Biobanking Drives Market Growth

The demand for storing biological samples for research and diagnostic purposes is booming. Biobanks are necessary for these samples' proper functionality, especially in massive population-based studies and clinical trials. The focus on precision medicine and individual healthcare approaches has strengthened the role of biobanks in genomic testing, biomarker discovery, and tailored treatments.

Continuous Advancements in Regenerative Medicine Boost the Biopreservation Market Demand

Regenerative medicine is becoming an essential part of the entire world's economy. Biopreservation is the main aspect that contributes to the continued vitality and usability of cells, tissues, and engineered constructs in both the present and future. Stem cells are commonly stored by cryopreservation methods such as freezing and vitrification for later use or other forms of treatment. Stem cell preservation protocols and cryoprotectants have been upgraded lately thus, the cells become stronger and more productive after the heating and cooling process ends.

Biopreservation Market Trends

Expansion of the Biopharmaceutical Industry

The biopharmaceutical industry, which specializes in creating and manufacturing therapeutic proteins, antibodies, vaccines, and cell therapies, is rapidly growing. Their shelf stability and quality require biopreservation throughout the product’s life span. This has led to a high demand for preservation techniques owing to their vulnerability to different environmental factors. If biopharmaceutical products are cryopreserved or lyophilized, they will have increased shelf life and product quality through proper testing for efficacy and safety._x000D_

Advancements in Cryopreservation Techniques

Enhancements in cryopreservation technology have positively enhanced the degree of biopreservation reliability. Techniques like vitrification and the application of cryoprotectants help to improve the successful rate of cells, tissues, and organs’ cryopreservation and decrease cell damage to a minimum during freeze and thaw procedures.

Increasing Focus on Personalized Medicine

The trend towards targeted medicines is contributing to the growth of biopreservation solutions. Specific therapies require genetically tailored biological materials as constituents of individualized care delivery. These must be stored optimally to retain their efficacy._x000D_

Emergence of Automated Biopreservation Systems

Automated systems in the process of biopreservation, such as robotics in the handling and controlling of temperature, are improving effectiveness with little or no human intervention. These systems provide stable and repeatable conditions for specimen storage, which is applicable for large-scale studies and biobanking.

Recent Developments in the Biopreservation Market

In April 2024, Thermo Fisher Scientific announced the launch of the TSX Universal Series Ultra-Low Temperature (ULT) Freezers, which will offer 33% energy savings and the best possible performance. These freezers enable the Universal V Drive technology for temperature control, faster recovery times, universal voltage, and an expanded setpoint range. They are Energy Star® certified and produced in a zero-waste to landfill accredited facility, thus enabling lab sustainability. The TSX Universal Series is perfect for biopreservation, guaranteeing the durability and integrity of our biological samples.

In September 2023, Avantor, Inc., one of the global providers of mission-critical products and services, collaborated with Tobin Scientific to manage end-to-end biopharmacy customer lab moves, research facilities, and sample relocation. The initiative's main goal is to provide temperature-specific logistics solutions to meet the uptick in demand, and it also ensures the safety and smooth travel of the required materials. The collaboration between Avantor and Tobin Scientific allows both short- and long-term storage solutions, which significantly decreases downtime and mocks temperature-controlled materials' Good Manufacturing Practice processes. Therefore, this process is significant for the protection of living tissues and the maintenance of the sample's homology throughout.

Biopreservation Market Segmentation

The report titled “Global Biopreservation Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product Type

• Biopreservation Equipment
• Biopreservation Media
• Others

Market Breakup by Application

• Regenerative Medicine
• Biobank
• Drug Discovery
• Others

Market Breakup by End User

• Hospitals
• Biobank
• Research and Academic Institutes
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Biopreservation Market Share

Biobank Application Expected to Hold the Largest Market Share

Based on the application, the market is divided into regenerative medicine, biobank, drug discovery, and others. Among these, biobanks are expected to lead the market share in the forecast period. Biobanks are specialized centers that are used for the storage and management of laboratory biological samples for research, clinical, or diagnostic purposes. They use biopreservation methodologies for long-term storage as well as usability. Biobanks are involved in research activities and multi-centre trials. Drug discovery applications also contribute to the demand for biopreservation, mainly because cell lines and primary cells are instrumental in screening, testing, and studying potential drugs.

Market Segmentation by Product Type is Projected to Experience Significant Growth

The market is segmented by product type into biopreservation equipment, biopreservation media and others. Among these biopreservation media is expected to dominate the market due to their pivotal function of keeping the cellular, tissue, and organ structures and capabilities intact and active during storage and transport. The large and expanding market for regenerative medicine, stem cell research, and personalized medicine has created the need for efficient and reliable preservation methods, thus propelling the biopreservation media segment.

Biopreservation Market Analysis by Region

Based on region, the market report is divided into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Among these, North America is expected to have the largest market share, attributable to the developed healthcare system, extensively developed medical research laboratories, pharmaceutical organizations, and biotechnology companies. The region has a dense network of biobanks, such as government-supported biobanks and local biobanks, for the collection and preservation of various types of biospecimens for research and commercial purposes.

The Asia Pacific region is another major consumer of these technologies. It has a large population and a growing biopharmaceutical industry.

Leading Players in the Global Biopreservation Market

The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:

BioLife Solutions, Inc.

Founded in 1998 and headquartered in the United States, they include CryoStor® freeze media, which maintains high post-thaw cell viability and recovery, and HypoThermosol® for storage and transportation of cells, tissues, and organs at low temperatures. These solutions are vital for retaining the virginity and functionality of tissues, organs, and other biological items that are preserved.

Thermo Fisher Scientific Inc.

Established in 1956 and based in the US, the company provides CryoMed® freezing containers and a controlled-rate freezer for freezing and preserving several types of biological material. Thermo Fisher also offers controlled-temperature storage solutions such as ultra-low-temperature freezers for sample storage in biobanking and biomedical research.

Other companies include Exact Sciences Corporation, Simport Scientific Inc., ThermoGenesis Holdings, Inc., Lifeline Scientific, MVE Biological Solutions and Princeton CryoTech.

Kindly note that this only represents a partial list of companies, and the complete list has been in the report.

Key Questions Answered in the Biopreservation Market

• What was the global biopreservation market value in 2024?
• What is the global biopreservation market forecast outlook for 2025-2034?
• What are the regional markets covered in the report?
• What is the market segmentation based on product type?
• What is the market breakup based on application?
• What factors are driving the expansion of biobanks and how are they influencing the demand for biopreservation solutions?
• What is the market segmentation based on end user?
• What are the major factors aiding the global biopreservation market demand?
• What are the market's major drivers, opportunities, and restraints?
• Which regional market is expected to lead the market share in the forecast period?
• Which country is expected to experience expedited growth during the forecast period?
• What are the major global biopreservation market trends?
• How does the rise in the geriatric population impact the market size?
• Who are the key players involved in the biopreservation market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.